Rhelion confirms further PEX010 delivery to Germany compassionate use program
Rhelion Life Sciences said it has confirmed further delivery of Filament Health's PEX010 to Germany’s First Psilocybin Compassionate Use Program.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.